- Home
- CODX vs KAPA Comparison
CODX vs KAPA Comparison
Compare CODX & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- KAPA
- Stock Information
- Founded
- CODX 2013
- KAPA 2013
- Country
- CODX United States
- KAPA United States
- Employees
- CODX N/A
- KAPA N/A
- Industry
- CODX Medical/Dental Instruments
- KAPA
- Sector
- CODX Health Care
- KAPA
- Exchange
- CODX Nasdaq
- KAPA NYSE
- Market Cap
- CODX 9.8M
- KAPA 10.8M
- IPO Year
- CODX 2017
- KAPA 2024
- Fundamental
- Price
- CODX $0.26
- KAPA $0.66
- Analyst Decision
- CODX Buy
- KAPA Strong Buy
- Analyst Count
- CODX 2
- KAPA 3
- Target Price
- CODX $5.50
- KAPA $8.33
- AVG Volume (30 Days)
- CODX 346.2K
- KAPA 1.5M
- Earning Date
- CODX 08-07-2025
- KAPA 08-23-2025
- Dividend Yield
- CODX N/A
- KAPA N/A
- EPS Growth
- CODX N/A
- KAPA N/A
- EPS
- CODX N/A
- KAPA N/A
- Revenue
- CODX $3,497,583.00
- KAPA N/A
- Revenue This Year
- CODX N/A
- KAPA N/A
- Revenue Next Year
- CODX $42.11
- KAPA N/A
- P/E Ratio
- CODX N/A
- KAPA N/A
- Revenue Growth
- CODX N/A
- KAPA N/A
- 52 Week Low
- CODX $0.23
- KAPA $0.40
- 52 Week High
- CODX $2.23
- KAPA $4.00
- Technical
- Relative Strength Index (RSI)
- CODX 42.29
- KAPA N/A
- Support Level
- CODX $0.27
- KAPA N/A
- Resistance Level
- CODX $0.30
- KAPA N/A
- Average True Range (ATR)
- CODX 0.02
- KAPA 0.00
- MACD
- CODX 0.00
- KAPA 0.00
- Stochastic Oscillator
- CODX 22.00
- KAPA 0.00
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.